ÂÜÀòÂÒÂ×

Xiaojun Guo has a strong background in drug safety and pharmacovigilance, with significant experience in leadership roles. Xiaojun is currently the Senior Director and Head of Drug Safety and Pharmacovigilance at Hutchison MediPharma since January 2017. Prior to that, they were the Head of Clinical Safety and Pharmacovigilance at GlaxoSmithKline from March 2012 to January 2017. Earlier in their career, they worked at AstraZeneca as an Associate Director for Patient Safety, Patient Safety Manager, and Research Alliance Leader. Xiaojun also had project management roles at Quintiles and Loudon Far East. Xiaojun Guo began their career as a Physician at the 2nd Hospital of Harbin Medical University.

Xiaojun Guo completed their Master's degree in Clinical Medicine from Harbin Medical University, from the year 1988 to 1997. Subsequently, they pursued a Doctorate degree in Internal Medicine-CV at the same university. The specific start and end years for their Doctorate program are not provided.